New Graves' drug enters first human safety trial
NCT ID NCT07305818
First seen Jan 04, 2026 · Last updated May 15, 2026 · Updated 24 times
Summary
This early-stage study tests a new drug called MER511 in 100 adults with Graves' disease. The main goal is to see if the drug is safe and what side effects it may cause. Participants will receive the drug either through a vein or under the skin, and blood tests will check how the body processes it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAVES DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Site # 1101
RECRUITINGHollywood, Florida, 33024, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Site # 1102
RECRUITINGRochester, Minnesota, 55905, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Site # 1103
RECRUITINGPhoenix, Arizona, 85053, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Site # 1104
RECRUITINGColumbus, Ohio, 43203, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Site # 1105
RECRUITINGWebster, Texas, 77598, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Site # 1107
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Site # 1108
RECRUITINGPhiladelphia, Pennsylvania, 19107, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.